The role of small RNA modifications in glioma

项目摘要/摘要 背景：包括microRNAs和tRNA相关片段(TRFs)在内的小的非编码RNA是重要的 它是全球基因表达的调节者，已被证明在正常发育中发挥关键作用。近期 有证据表明，小的RNAs(特别是TRFs)可以通过修饰来调节，然而全球分析 由于缺乏工具，用于癌症的小RNA修饰的研究仍然缺乏。在这个提案中，我将测试 小RNA修饰的失调在癌症生物学中起着重要作用。我将重点介绍胶质瘤/胶质母细胞瘤。 (GBM)，几乎无法治疗的恶性癌症类型。 研究：候选人的初步结果表明，TRFs是基因表达的新调节器， 胶质瘤的细胞表型及其活性可能受小RNA修饰状态的调节。这个 候选人已经在GBM和GSC(胶质瘤干细胞样细胞)细胞系中检测到这种小RNA修饰 还有GBM患者。这项建议旨在了解这些新发现的细胞的生物学功能 胶质瘤中的小RNA修饰和转录因子。如果完成，这将为该领域带来新的见解，并成为 成立独立实验室的完美利基。提出了三个目标，每个目标都基于初步数据，以及 进入独立阶段。目的1确定与胶质瘤相关的小RNA修饰因子。 目标2将确定胶质瘤预后相关转录因子的功能作用和靶点。目标3将阐明新的RBP- 胶质瘤中小RNA修饰调控TRF靶组和通路的基础机制。GSC 培养和小鼠异种移植、基因组学和生物信息学将被用来解决这些问题。这个 拟议的研究计划将揭示一种新的基因调控机制，通过小RNA修饰和 确定胶质瘤治疗的潜在治疗靶点。 应聘者：候选人的长期目标是利用她在生物化学、小RNA和 分子生物学，以了解癌症生物学中新的基因调控机制。她已经在处理一个 进行拟议的实验所需的许多技能，但她非常需要获得额外的 在胶质瘤生物学方面的培训，以进一步验证她的假设(与共同导师谁是GBM领域的专家)。 K99指导阶段将允许她在当前数据的基础上进行构建，在几个新领域进行扩展，并学习 建立自己的实验室的新技术。建议成立一个由6人组成的指导委员会，以确保候选人获得 帮助她实现独立的指导。 环境：拟议的项目将在弗吉尼亚大学进行，该大学有一个杰出的 为拟议的培训和研究提供环境。

PROJECT SUMMARY/ABSTRACT Background: Small non-coding RNAs including microRNAs and tRNA-related fragments (tRFs) are important regulators of global gene expression and have been shown to play key roles in normal development. Recent evidence suggests small RNAs (especially tRFs) can be regulated via modifications, however global analysis of small RNA modifications in cancers is still lacking due to lack of tools. In this proposal I will test whether dysregulation of small RNA modifications play a role in cancer biology. I will focus on glioma/glioblastoma (GBM), vicious cancer types that are barely treatable. Research: The candidate's preliminary results indicate that tRFs are novel regulators of gene expression and cell phenotypes in gliomas and their activity could be regulated by small RNA modification status. The candidate already detected such small RNA modifications in GBM and GSC (glioma stem-like cells) cell lines and also GBM patients. This proposal aims to understand the biological functions of these newly identified small RNA modifications and tRFs in gliomas. If completed, this will bring novel insights to the field and be a perfect niche to launch an independent lab. Three aims are proposed, each based on preliminary data, and taking into the independent phase. Aim 1 will determine the glioma-relevant small RNA modification factors. Aim 2 will define the functional roles and targetome of glioma-prognostic tRFs. Aim 3 will elucidate novel RBP- based mechanisms of small RNA modification regulating tRF targetome and pathways in gliomas. GSC cultures and mouse xenografts, genomics and bioinformatics will be employed to tackle these questions. The proposed research plan will reveal a novel gene regulatory mechanism by small RNA modifications and identify potential therapeutic targets for glioma treatment. Candidate: The candidate's long-term goal is to utilize her background in biochemistry, small RNA and molecular biology to understand new gene regulatory mechanism in cancer biology. She already processes a lot of the skills needed to conduct proposed experiments, however she is in great need to obtain additional training in glioma biology in order to further test her hypothesis (with co-mentor who is an expert in GBM field). The K99 mentored phase will allow her to build on her current data, expand on several new areas, and learn new techniques to launch her own lab. A mentoring committee of 6 is proposed to ensure the candidate get guidance to help her achieve independence. Environment: The proposed project will be conducted at University of Virginia, which has an outstanding environment for the proposed training and research.